Finance

Lists
NAV:CVE
Navco Pharmaceuticals Inc
CA$0.0050
0.00%
(0.00) 1D
ኦክቶ 28, 1:31:29 ከሰዓት ጂ ኤም ቲ-5  ·   CAD
All symbols
SymbolPriceChange% Change
Generating top insights for NAV...
Mkt. cap
285.35 ሺ
Avg. vol.
806.00
Volume
0.00
52-wk high
CA$0.01
52-wk low
CA$0.00
EPS
-CA$0.00
Beta
14.27
Shares outstanding
57.07 ሚ
Mkt. cap
285.35 ሺ
Avg. vol.
806.00
Volume
0.00
52-wk high
CA$0.01
52-wk low
CA$0.00
EPS
-CA$0.00
Beta
14.27
Shares outstanding
57.07 ሚ
News stories
From web sources and news partners
About Navco Pharmaceuticals Inc
CEO-
Employees-
Founded-
Headquartersቫንኩቨር, ብሪቲሽ ኮለምቢያ, ካናዳ
SectorHealth Care
IndustryBiotechnology
Websitenavcopharma.com
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
ሴፕቴ 2025
ዲሴም 2025
ማርች 2026
ጁን 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
34.77 ሺ
2.06 ሺ
2.95 ሺ
1.58 ሺ
Operating expense
34.77 ሺ
2.06 ሺ
2.95 ሺ
1.58 ሺ
Total operating expenses
34.77 ሺ
2.06 ሺ
2.95 ሺ
1.58 ሺ
Operating income
-34.77 ሺ
-2.06 ሺ
-2.95 ሺ
-1.58 ሺ
Other non operating income
-2.27 ሺ
-1.16 ሺ
-10.54 ሺ
-1.91 ሺ
EBT including unusual items
-39.64 ሺ
-5.83 ሺ
-16.55 ሺ
-6.82 ሺ
EBT excluding unusual items
-39.64 ሺ
-5.83 ሺ
-16.55 ሺ
-6.82 ሺ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-39.64 ሺ
-5.83 ሺ
-16.55 ሺ
-6.82 ሺ
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-2.61 ሺ
-2.61 ሺ
-3.06 ሺ
-3.33 ሺ
Net interest expenses
-2.61 ሺ
-2.61 ሺ
-3.06 ሺ
-3.33 ሺ
Depreciation and amortization charges
-
-
-
-
EBITDA
-26.38 ሺ
-
-
-
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google መተግበሪያዎች